Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Absorbable in natural tissue
Reexamination Certificate
1997-07-07
2002-01-01
Milano, Michael J. (Department: 3738)
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Absorbable in natural tissue
C623S023720, C623S023750
Reexamination Certificate
active
06334872
ABSTRACT:
FIELD OF THE INVENTION
This invention is in the field of tissue engineering. The present invention is a resilient, biocompatible two- or three-layered tissue graft which can be engineered in flat sheets or in tubes with various luminal diameters and thicknesses. At least one layer is composed of collagen or a collagenous material. The present invention is gradually degraded and bioremodeled by the host's cells which replace the implanted prosthesis and assume its shape.
BACKGROUND OF THE INVENTION
Each year approximately 300,000 coronary bypass procedures are performed in the United States. The typical treatment for small diameter artery replacement has been for surgeons to use the patient's own vessels, usually the saphenous vein from the leg. However, in many cases, the use of the patient's own vessels is not practical because the veins are either damaged, diseased or are not available. In these cases, synthetic materials are used, but with unsatisfactory long-term results. It is still a continuing goal of researchers to develop prostheses which can successfully be used to replace or repair mammalian tissue, particularly blood vessels.
SUMMARY OF THE INVENTION
This invention is directed to a method for treating damaged or injured organs, particularly blood vessels, by replacing, or repairing, a section of the organ in a patient with a bioremodelable collagen graft prostheses. This prosthesis, when implanted into a mammalian host, undergoes controlled biodegradation accompanied by adequate living cell replacement, or neo-tissue formation, such that the original implanted prosthesis is bioremodeled by the host's cells before it is digested by host enzymes. The prosthesis of this invention comprises at least two layers: (a) at least one layer is composed of collagen or a collagenous material; and (b) at least one layer is composed of material which provides structural stability, and is pliable, semi-permeable, and suturable. In the preferred embodiment of this invention, the two-layered prosthesis has an inner (luminal) layer which provides a smooth, thrombosis-resistant flow surface and an outer structural layer which provides structural stability, and is pliable, semi-permeable, and suturable. In another preferred embodiment of this invention the prosthesis has three layers: an inner (luminal) layer which acts as a smooth, thrombosis-resistant flow surface; a middle structural layer which provides structural stability, and is pliable, semi-permeable, and suturable; and, an outer (abluminal) layer. The outer layers of both the two-layer or the three-layer prosthesis add strength to the graft and allow the patient's host cells to attach and grow into the graft thereby facilitating the bioremodeling.
The invention is also directed to methods for preparing bioremodelable two-or three-layer tubular blood vessel prostheses by (a) forming a tubular structural layer that is pliable, semi-permeable, and suturable; (b) forming an inner layer to act as a smooth flow surface comprising deposition of acid-extracted fibrillar collagen onto the luminal surface of said structural layer of step (a); and, (c) creating the lumen. The inner layer may also be treated with drugs for anti-thrombotic effect, such as heparin or other appropriate agent(s). The prosthesis is next implanted into a mammalian host where it undergoes controlled biodegradation accompanied by adequate living cell replacement, or neo-tissue formation, such that the original implanted prosthesis is bioremodeled by the host's cells.
REFERENCES:
patent: 3272204 (1966-09-01), Artandi
patent: 3562820 (1971-02-01), Braun
patent: 4082507 (1978-04-01), Sawyer
patent: 4252759 (1981-02-01), Yannas et al.
patent: 4319363 (1982-03-01), Ketharanathan
patent: 4420339 (1983-12-01), Kato
patent: 4502159 (1985-03-01), Woodroof et al.
patent: 4539716 (1985-09-01), Bell
patent: 4629458 (1986-12-01), Pinchuk
patent: 4787900 (1988-11-01), Yannas
patent: 4801299 (1989-01-01), Brendel et al.
patent: 4814120 (1989-03-01), Huc et al.
patent: 4822361 (1989-04-01), Okita et al.
patent: 4842575 (1989-06-01), Hoffman, Jr. et al.
patent: 4902289 (1990-02-01), Yannas
patent: 4902290 (1990-02-01), Fleckenstein et al.
patent: 4902508 (1990-02-01), Badylak
patent: 4923380 (1990-05-01), Huc et al.
patent: 4956178 (1990-09-01), Badylak et al.
patent: 5002583 (1991-03-01), Pitaru
patent: 5024671 (1991-06-01), Tu et al.
patent: 5026381 (1991-06-01), Li
patent: 5037377 (1991-08-01), Alonso
patent: 5061276 (1991-10-01), Tu et al.
patent: 5084065 (1992-01-01), Weldon et al.
patent: 5106949 (1992-04-01), Kemp et al.
patent: 5108424 (1992-04-01), Hoffman, Jr. et al.
patent: 5197977 (1993-03-01), Hoffman, Jr. et al.
patent: 5256418 (1993-10-01), Kemp et al.
patent: 5263983 (1993-11-01), Yoshizato et al.
patent: 5374515 (1994-12-01), Parenteau et al.
patent: 5376110 (1994-12-01), Tu et al.
patent: 5376376 (1994-12-01), Li
patent: 5378469 (1995-01-01), Kemp
patent: 5460962 (1995-10-01), Kemp
patent: 5733337 (1998-03-01), Carr
patent: 5776182 (1998-07-01), Bruchman
patent: 5851230 (1998-12-01), Weadock
patent: 5879383 (1999-03-01), Bruchman
patent: 5948654 (1999-09-01), Tranquillo
patent: 5968092 (1999-10-01), Buscemi
patent: 5993844 (1999-11-01), Abraham
patent: 0 397 500 (1990-11-01), None
patent: 0 493 788 (1992-07-01), None
patent: 2153235 (1985-08-01), None
patent: WO 89/10100 (1989-11-01), None
Matsumoto, T. et al.; (1966), The Fate of the Inverted Segment of Small Bowel Used for the Replacement of Major Veins; Surgery, vol. 60 (3), pp. 739-743.
Fraser, R.E. et al.; (1968); Experimental Replacement of the Superior Vena Cava; Arch. Surg. vol. 96, pp. 378-385.
Egusa, S.; (1968); Experimental Study on Vascular Graft II. Replacement of Inferior Vena Cava and Abdominal Aorta with the Autogenous Segment of Samll Intestinal Submucosal; Acta Med. Okayama 22, pp. 153-165.
Lawler, M.R., Jr. et al.; (1971); Evaluation of Canine Intestinal Submucosa as a Vascular Substitute; The American Journal of Surgery, vol. 122, pp. 517-519.
Dagan, R. et al., (1983); Glutaraldehyde Treated Cat Small Bowel as an Arterial Graft; Vascular Surgery, Jul/Aug, pp. 199-206.
Broll, R. et al.; (1986); Replacement of Dog's Aorta by Autologous Intestinal Muscle in the Infected Retroperitoneum; Eur. Surg. Res., vol. 18, pp. 390-396.
American National Standard for Vascular Graft Prostheses; Association for the Advancement of Medical Instrumentation, approved July 7, 1986.
Hiles, M.C. et al.; (1993); Porosity of Porcine Small-Intestinal Submucosa for Use as a Vascular Graft; Journal of Biomed. Material Res., vol. 27, pp. 139-144.
Carr. R.M. et al.; (1994); The Study of the Release of Benzalkonium-Heparin Complex from an Absorbable Synthetic Colagen Graft; The 20th Annual Meeting of the Society for Biomaterials, Apr. 5-9, Boston, MA.
Haimovici, H.; Patch Graft Angioplasty; Vascular Surgery, Third Edition, pp. 287-292.
Silverman, G.J.; Sterilizaton and Preservation by Ionizing Irradiation; InDisinfection, Sterilization, and Preservation,Fourth Ed., London-Philadelphia, Lea & Febiger, Ch. 32, pp. 566-579.
Abbott, W.M. et al.; (1993) Evaluation and Performance Standards for Aterial Prostheses, Journal of Vascular Surgery, vol. 17, No. 4, pp. 746-756.
Termin, P.L. et al.; (1994); Remodeling of an Absorbable Synthetic Collagen Graft: Long Term Implant Histology, The 20th Annual Meeting of the Society for Biomaterials, Apr. 5-9, Boston. MA.
Carr, Jr. Robert M.
Condon Kimberlie D.
Termin Paul L.
Milano Michael J.
Organogenesis Inc.
LandOfFree
Method for treating diseased or damaged organs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating diseased or damaged organs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating diseased or damaged organs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2862212